Paragon Care Limited (ASX:PGC)

Market Cap	339.34M -57.7%
Revenue (ttm)	3.61B +21.7%
Net Income	20.57M +151.5%
EPS	0.01 +42.5%
Shares Out	1.66B
PE Ratio	16.53
Forward PE	9.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	455,513
Average Volume	981,931
Open	0.2100
Previous Close	0.2100
Day's Range	0.2050 - 0.2100
52-Week Range	0.2000 - 0.5650
Beta	1.42
RSI	39.02
Earnings Date	Feb 24, 2026

About Paragon Care

Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provides neonatal and paediatric assessment, including newborn hearing and vision screening, jaundice management, NICU video monitoring, brain monitoring, b...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2005
• Employees: 550
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: PGC

Financial Performance

In fiscal year 2025, Paragon Care's revenue was 3.61 billion, an increase of 21.68% compared to the previous year's 2.97 billion. Earnings were 20.57 million, an increase of 151.52%.